WebCryptoMedixGeneral Information Description Developer of proprietary technology for cancer and certain inflammatory diseases. The company is focused on the commercialization of a portfolio of biologics and diagnostic agents with the potential for cancer and certain inflammatory diseases. Contact Information Website www.cryptomedix.com WebCurrent: - Chairman of the Board of Directors, OXFORD BIOTHERAPEUTICS (U.K.) - Co-Founder, Executive Chairman/Interim CEO, CRYPTOMEDIX (U.S.) - Board of Directors, Co-Chair, Scientific Advisory ...
Dr. Bernd Seizinger, M.D., Ph.D. - Advisory Board - LinkedIn
WebCryptoMedix is a biotech company in the field of Oncology, developing highly innovative anticancer therapeutics. Targeting the tumor microenvironment New Website Coming Soon WebCryptoMedix LLC is a biotechnology company that engages in the discovery, clinical development, and commercialization of a portfolio of therapeutic … how many different drugs exist
Lennie Liebes - Sciientific Director - Cryptomedix inc LinkedIn
WebCryptoMedix is a biotech company in the field of Oncology, developing highly innovative anticancer therapeutics. Popular Searches. CryptoMedix. Cryptomedix LLC. Cryptomedix Inc. Revenue. $4 M. Employees. 14. Primary Industries. Manufacturing Pharmaceuticals. CryptoMedix Executive Team & Key Decision Makers. Name & Title WebCryptoMedix is a company that provides Pharmacy and Therapeutics and more. CryptoMedix is headquartered in United States Maine. CryptoMedix was founded in 2013. Related Topics. Pharmacy and Therapeutics. Login to view all basic info. Data Snapshot. 1. Funding. High Related Markets. WebWebsite: http://cryptomedix.com/ Our first-in-class therapeutic antibodies promote the migration/function of cytotoxic T-cells (which kill tumor cells), and inhibit the migration/function of tumor-suppressive macrophages in the TME. high temperature thread sealant